The UK is leading the way in continuing to develop a rich genomic ecosystem which is growing across academia, healthcare and private companies.
Genomics England draws on these talents and innovations to drive forward genomics programmes in the UK.
The Genomics Nation 2022 report highlights future opportunities for the UK genomics sector. Cambridge is leading the UK, with top investors in the genomics cluster. According to the report: 'The top three investors in this sector are entities with strong links to the University of Cambridge – once again emphasising the important role played by those institutions commercialising academic research within the genomic community.'